Advancements in the Management of Gynecological Cancers: ESMO 2024 - Episode 10
Panelists discuss their approach to biomarker testing in advanced endometrial cancer, including the timing and types of testing performed, the specific biomarkers assessed (such as mismatch repair/microsatellite instability, POLE, and TP53), and how these results inform treatment decisions.
Video content above is prompted by the following:
How do you typically approach biomarker testing for advanced endometrial cancer?